SPOTLIGHT -
Letter: Declassifying Gleason 6 as a cancer would do more harm than good
"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.
Using bisphosphonates to treat PCa-related bone events
Prostate cancer is the most prevalent non-cutaneous cancer diagnosed in men today, still accounting for a significant amount of morbidity and mortality in spite of increased screening efforts and advances in treatment.